logo
  

Ocugen Gets Positive DSMB Recommendation For OCU400-101 Clinical Trial

Biotechnology company Ocugen, Inc. (OCGN) announced Monday that the independent Data and Safety Monitoring Board (DSMB) for its Phase 1/2 clinical trial of OCU400 recommended that the Company continue enrolling the remaining study subjects in this current cohort at the target dose level.

This recommendation was after reviewing safety data based on dosing to date and recommended that the study proceed with enrolling additional subjects.

OCU400 is the Company's flagship modifier gene therapy candidate for the treatment of Retinitis Pigmentosa (RP).

The OCU400-101 clinical study to assess the safety and efficacy of modifier gene therapy candidate OCU400 for RP resulting from mutations in the nuclear receptor subfamily 2 group E member 3 (NR2E3) and Rhodopsin (RHO) genes recently dosed its first patient.

Ocugen's modifier gene therapy platform targets nuclear hormone receptors (NHRs) that regulate multiple functions within the retina, giving it the potential to address many different gene mutations - and in turn, multiple retinal diseases - with a single product.

Traditional gene therapy, which transfers a functional version of a non-functional gene into target cells, addresses only one individual gene mutation at a time.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Ice Cream maker Ben & Jerry's reportedly filed a lawsuit against parent and British consumer giant Unilever to stop the sale of its Israeli business to a local license-holder Avi Zinger. The company alleged that the decision was made without the approval of its independent board. The judge reportedly denied Ben & Jerry's application for a temporary restraining order against Unilever. J&M Foods is recalling certain Lavender Shortbread Cookies sold through department store chain Target Corp. due to undeclared allergens, the U.S. Food and Drug Administration said. These packages were erroneously packed with Chocolate Chip Cookies and do not disclose the presence of a possible allergen, such as soy or eggs. A multi-state listeria outbreak that has killed one and sickened at least 23 others has been linked to Florida -based Big Olaf Creamery brand ice cream, according to the Centers for Disease Control and Prevention or CDC. The outbreak strain has been reported from 10 states, resulting in 22 hospitalizations. One death has been reported from Illinois.
RELATED NEWS
Follow RTT